Genetic Signatures Share Price and Company Fundamentals



Price
$1.19
Change
0.015 (1.277%)
52 week
1.15 - 2.94

Last traded: Today at 6:10 AM

Genetic Signatures Limited operates as a molecular diagnostic (MDx) company in North America and Australia. The company designs and manufactures a suite of real-time polymerase chain reaction based products for detection of infectious diseases under EasyScreen brand name. It also provides MDx 3Base platform technology that enables hospital and pathology laboratories to screen for a range of infectious pathogens. Genetic Signatures Limited was founded in 2001 and is headquartered in Sydney, Australia.

Key Metrics

PE ratio

36.06

PB ratio

3.31

Dividend yield

Beta

-0.45

Market cap

$170.06M

Enterprise value

$134.13M

Company profile

Primary activitiesMolecular Diagnostics.
Industry / SectorDiagnostics & Research / Healthcare
Websitehttp://www.geneticsignatures.com
Mailing address7 Eliza Street Newtown Sydney NSW 2042 Australia
Phone / Fax61 2 9870 7580 /
Share registryBOARDROOM PTY LIMITED

Dividends

Genetic Signatures does not pay dividends.

Company Executives

As of May 2021, following are the company executives and directors listed on Genetic Signatures.

NameTitleAgeTotal Pay
Dr. John R. MelkiMD, CEO & Exec. Director524.92k
Mr. Peter ManleyCFO & Company Sec.306.46k
Mr. Michael Anton Aicher M.B.A., BSc, MBAExec. Director of US Operations & Exec. Director60178.1k
Mr. Christopher M. AbbottFounder & Chairman Emeritus
Dr. Douglas S. Millar BSc, Ph.D.Chief Scientific Officer
Mr. Jackson JonesDirector of Global Sales & Marketing
Mr. Patrick Noland BSc, MBAUS Market Consultant

Profitability and management effectiveness

Profit margin

16.33%

Operating margin

15.99%

Return on assets

5.61%

Return on equity

9.98%

Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.

The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.

Valuation and Trading Info

The market capitalization of Genetic Signatures is 170.06M and its enterprise value is 134.13M. The enterprise value to revenue ratio of GSS is 4.61.

Companies similar to Genetic Signatures (GSS)

Genetic Signatures (ASX:GSS) Frequently Asked Questions

1. What is Genetic Signatures's Stock Symbol?

Genetic Signatures trades on ASX under the ticker symbol "GSS".

2. What is Genetic Signatures's stock price today?

One share of GSS stock can currently be purchased for approximately $1.19.

3. How can I contact Genetic Signatures?

Genetic Signatures's mailing address is 7 Eliza Street Newtown Sydney NSW 2042 Australia. The company can be reached via phone at 61 2 9870 7580.

4. What is Genetic Signatures's official website?

The official website of Genetic Signatures is http://www.geneticsignatures.com.

5. Which share registry manages Genetic Signatures's stock?

Genetic Signatures's stock is managed by BOARDROOM PTY LIMITED.